Global Angioedema Treatment Market To Reach Worth USD 1,658.0 Mn By 2022: Credence Research
According to the latest report published by Credence Research, Inc. “Angioedema Treatment Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the angioedema market was valued at USD 895.4 Mn in 2015, and is expected to reach USD 1,658.0 Mn by 2022, expanding at a CAGR of 9.2% from 2016 to 2022. Browse the full report Angioedema Treatment Market Growth, Future Prospects and Competitive Analysis, 2016-2022report at http://www.credenceresearch.com/report/angioedema-treatment-market
According to the latest report published by Credence Research, Inc. “Angioedema Treatment Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the angioedema market was valued at USD 895.4 Mn in 2015, and is expected to reach USD 1,658.0 Mn by 2022, expanding at a CAGR of 9.2% from 2016 to 2022.
Browse the full report Angioedema Treatment Market Growth, Future Prospects and Competitive Analysis, 2016-2022report at http://www.credenceresearch.com/report/angioedema-treatment-market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Global</strong> <strong>Angioedema</strong> <strong>Treatment</strong> <strong>Market</strong> <strong>To</strong> <strong>Reach</strong> <strong>Worth</strong> <strong>USD</strong><br />
1,<strong>658.0</strong> <strong>Mn</strong> <strong>By</strong> <strong>2022</strong>: <strong>Credence</strong> <strong>Research</strong><br />
According to the latest report published by <strong>Credence</strong> <strong>Research</strong>, Inc. “<strong>Angioedema</strong> <strong>Treatment</strong> <strong>Market</strong><br />
Growth, Future Prospects and Competitive Analysis, 2016-<strong>2022</strong>,” the angioedema market was valued at<br />
<strong>USD</strong> 895.4 <strong>Mn</strong> in 2015, and is expected to reach <strong>USD</strong> 1,<strong>658.0</strong> <strong>Mn</strong> by <strong>2022</strong>, expanding at a CAGR of 9.2%<br />
from 2016 to <strong>2022</strong>.<br />
Browse the full report <strong>Angioedema</strong> <strong>Treatment</strong> <strong>Market</strong> Growth, Future Prospects and Competitive<br />
Analysis, 2016-<strong>2022</strong>report at http://www.credenceresearch.com/report/angioedema-treatment-market<br />
<strong>Market</strong> Insights<br />
Growth in healthcare investments, prevalence of angioedema and growing high-risk geriatric population<br />
are the major factors driving the global market growth for angioedema treatment. North America is the<br />
largest regional market at a market share of over 41% in 2015, and the dominance of this region is<br />
anticipated to continue through <strong>2022</strong>. Rising incidence of angioedema and high awareness about<br />
treatment and the management of angioedema together drive the North America angioedema market.<br />
Asia Pacific is expected to be the fastest growing market in the global angioedema market due to rising<br />
prevalence rate in the countries like Japan, China and others. Moreover, the growing research and<br />
development in the drug discovery of angioedema would further drive the market during the forecast<br />
period.<br />
Browse All Reports of This Category @ http://www.credenceresearch.com/industry/pharmaceuticalsmarket<br />
The treatment types include Antihistamines, Corticosteroids, Autoimmune drugs, antifibrinolytic agents<br />
and blood protein controllers. Antihistamines and Corticosteroids accounted for approximately 45% - 50%<br />
of the total market share because these are the first line therapies preferred by the medical practitioners<br />
and majorly used as supportive therapies and most accessible source of treatment across the globe.<br />
Despite the high cost of new treatment options in comparison to older therapies such as attenuated<br />
androgens and antifibrinolytic agents, they are popular with physicians due to the superior control offered<br />
over symptoms such as subcutaneous and abdominal swelling. These highly priced drugs have therefore<br />
managed to capture a high prescription share. Hence, introduction of new drugs with further improved<br />
effectiveness and safety will drive the global angioedema market during the forecast period.<br />
Request free sample - http://www.credenceresearch.com/sample-request/58017
About Us:<br />
<strong>Credence</strong> <strong>Research</strong> is a worldwide market research and counseling firm that serves driving organizations,<br />
governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance<br />
with making enduring enhancements to their execution and understand their most imperative objectives.<br />
Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.<br />
Who we are<br />
<strong>Credence</strong> <strong>Research</strong> is a worldwide firm, containing more than 15 research consultants and almost 100<br />
research and information professionals.<br />
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia<br />
Pacific and 12% in the Middle East and Africa.<br />
Our firm is intended to work as one. We are a solitary global research organization united by a solid<br />
arrangement of qualities, concentrated on customer effect.<br />
What we do<br />
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether<br />
as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each<br />
engagement, we collect a group with the most suitable experience and ability.<br />
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing<br />
our customers to develop and lead. We join forces with customers to place suggestions into practice. Our<br />
research specialist work straightforwardly with customers over long stretches to create workforce<br />
aptitudes, drive operational change, and apply new working strategies.<br />
Media Contact<br />
Name: Chris Smith (<strong>Global</strong> Sales Manager)<br />
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US<br />
E-mail: sales@credenceresearch.com<br />
Ph: 1-800-361-8290<br />
Web: http://www.credenceresearch.com
Change language